Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Allain

Showing results (81-90 of 187) with videos related to

Pageof 19
Sort By:
Therapie|July 8, 1999
[Adverse effects and drugs for Alzheimer's disease]S Schück, D Bentué-Ferrer, C Beaufils, et al.
Clinical Therapeutics|May 1, 1993
Effect of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjectsH Allain, P Raoul, A Lieury, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|December 1, 1980
[Hyperparathyroidism secondary to cirrhosis. Arguments supplied by ionized calcium, urinary cyclic AMP and blood N-terminal parathyroid hormone]J Y Louboutin, A Feuillu, H Allain, et al.
Therapie|May 1, 1987
[18 months' tracking of a drug surveillance survey in dermatology. Methodological evaluation at 30 months]H Allain, M Pibouin, C Bénéton, et al.
Clinical Therapeutics|January 1, 1997
Drugs used in Alzheimer's disease and neuroplasticityH Allain, D Bentue-Ferrer, J M Gandon, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1982
[Hemodynamic and biological effects of bromocriptine in essential hypertension]H Allain, J C Daubert, C Massart, et al.
La Nouvelle Presse Medicale|September 10, 1979
[Shy and Drager syndrome. Physiopathological and pharmacological approach based upon one case (author's transl)]H Allain, D Bentue-Ferrer, R Brissot, et al.
Clinical Neuropharmacology|June 1, 1989
Pregnancy and parkinsonism. A case report without problemH Allain, D Bentue-Ferrer, D Milon, et al.
Presse Medicale (Paris, France : 1983)|October 13, 1998
[Drugs on the Internet. Hazards of public health]P Y Allain, S Schuck, C Beaufils, et al.
Clinical Pharmacology and Therapeutics|September 5, 1998
Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitorP Rosenzweig, A Patat, I Zieleniuk, et al.
Pageof 19

Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
Therapie|July 8, 1999
[Adverse effects and drugs for Alzheimer's disease]S Schück, D Bentué-Ferrer, C Beaufils, et al.
Clinical Therapeutics|May 1, 1993
Effect of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjectsH Allain, P Raoul, A Lieury, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|December 1, 1980
[Hyperparathyroidism secondary to cirrhosis. Arguments supplied by ionized calcium, urinary cyclic AMP and blood N-terminal parathyroid hormone]J Y Louboutin, A Feuillu, H Allain, et al.
Therapie|May 1, 1987
[18 months' tracking of a drug surveillance survey in dermatology. Methodological evaluation at 30 months]H Allain, M Pibouin, C Bénéton, et al.
Clinical Therapeutics|January 1, 1997
Drugs used in Alzheimer's disease and neuroplasticityH Allain, D Bentue-Ferrer, J M Gandon, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1982
[Hemodynamic and biological effects of bromocriptine in essential hypertension]H Allain, J C Daubert, C Massart, et al.
La Nouvelle Presse Medicale|September 10, 1979
[Shy and Drager syndrome. Physiopathological and pharmacological approach based upon one case (author's transl)]H Allain, D Bentue-Ferrer, R Brissot, et al.
Clinical Neuropharmacology|June 1, 1989
Pregnancy and parkinsonism. A case report without problemH Allain, D Bentue-Ferrer, D Milon, et al.
Presse Medicale (Paris, France : 1983)|October 13, 1998
[Drugs on the Internet. Hazards of public health]P Y Allain, S Schuck, C Beaufils, et al.
Clinical Pharmacology and Therapeutics|September 5, 1998
Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitorP Rosenzweig, A Patat, I Zieleniuk, et al.
Pageof 19